Moderna (MRNA) ticks higher after U.S. calls for a pause in &J (JNJ) vaccine after clotting cases
- Wall St opens flat ahead of Easter break, eyes sharp Q1 gains
- Home Depot agrees to buy SRS Distribution, sees TAM expanding to $1 trillion
- Stocks head into quarter-end on the up; yen on intervention watch
- Dollar gains as inflation data looms; yen on intervention watch
- Piper Sandler: Stock rally likely to continue on rising recession risks
- AMC Entertainment (AMC) enters into an equity distribution agreement
- Discover Financial Services (DFS) Announces CEO Resignation
- Timken (TKR) Appoints Tarak Mehta as New CEO
- Crude Inventory Increases 3.2 Million Barrels
- Intuitive Machines (LUNR) Files for $300M Share Offering, 160M Share Offering by Selling Stockholders
Johnson & Johnson (JNJ) Vaccine Pause Expected to be Matter of Days, Says FDA
April 13, 2021 10:17 AM EDTJohnson & Johnson (NYSE: JNJ) Vaccine Pause Expected to be Matter of Days, Says FDA
Johnson & Johnson (JNJ) Statement on COVID-19 Vaccine
April 13, 2021 9:22 AM EDTJohnson & Johnson (NYSE: JNJ) announced:
The safety and well-being of the people who use our products is our number one priority. We are aware of an extremely rare disorder involving people with blood clots in combination with low platelets in a small number of individuals who have... More